Alar Pharmaceuticals Inc. (TPEX: 6785)
Health Care · Pharmaceuticals · TW
NT$100.00
+1.42% today · -42.4% 1Y
Alar Pharmaceuticals Inc. (TPEX: 6785) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $208.78M and employs 32 people.
Over the last twelve months the share price has lost 42.4%, trading between 92.00 and 317.00.
Tweenvest scores Alar Pharmaceuticals Inc. across four factors: quality 42/100, dividend 4/100. Its strongest factor is quality.
6785 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $208.78M
- Revenue (TTM)
- $94.30K
- P/E
- —
- EPS
- -1.07
- Dividend yield
- 0.10%
- Beta (5Y)
- 0.12
- 52-week high
- NT$317.00
- 52-week low
- NT$92.00
- Avg volume (3M)
- —
- Shares outstanding
- 66.80M
- Employees
- 32
- Next earnings
- —
About Alar Pharmaceuticals Inc.
Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
- ISIN
- TW0006785009
- Founded
- 2016
- Listed since
- Oct 5, 2020
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.